Kasibel SRL
The score of Kasibel shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +179 % Total assets +74 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Kasibel's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 08 Jul 2026
- Year ended 31 Dec 2024filed on 12 Jun 2025
- Year ended 31 Dec 2023filed on 17 Jun 2024
- Year ended 31 Dec 2022filed on 23 Jun 2023
- Year ended 31 Dec 2021filed on 12 Jun 2022
Kasibel's financial analysis
- Solvency74.1%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Kasibel
Kasibel's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0843.754.401
- VAT number
- BE0843754401
- Peppol
- Registered · 0208:0843754401 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Feb 2012
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 08 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Kasibel (SRL) has been based in Uccle since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 347 € and equity of 15,290 €; its revenue is not published. Its solvency stands at 74.1%, above the median of its sector (37.8%).
Companies similar to Kasibel
Companies in the same business, of comparable size and area, outside its group.
- PharmaSave Retail sale of pharmaceutical products Antwerp · balance sheet 20,063 €
- Eklosium Retail sale of pharmaceutical products Schaerbeek · balance sheet 21,432 €
- Apotheek Vandyck Retail sale of pharmaceutical products Anderlecht · balance sheet 21,647 €
- Ajaga Retail sale of pharmaceutical products Knokke-Heist · balance sheet 21,992 €
- JL Pharma Retail sale of pharmaceutical products Stoumont · balance sheet 22,608 €
- Camille Huby Retail sale of pharmaceutical products Etterbeek · balance sheet 18,562 €
- TVB Consult Retail sale of pharmaceutical products Kruisem · balance sheet 17,370 €
- Farmaco Retail sale of pharmaceutical products Ranst · balance sheet 17,325 €
Frequently asked questions about Kasibel
What is the revenue of Kasibel?
Kasibel files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Kasibel?
In Belgium, the VAT number is the company number prefixed with BE: BE0843754401 for Kasibel, if the company is VAT-registered. Its company number (CBE) is 0843.754.401.
Where is the registered office of Kasibel?
According to the CBE register, the registered office of Kasibel is in 1180 Uccle.
What is the equity of Kasibel?
At the close of the 2025 financial year, the equity of Kasibel amounts to 15,290 €, a solvency of 74.1% of total assets.
Who manages Kasibel?
The register lists 1 active mandates at Kasibel. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Kasibel
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →